Compare TUYA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TUYA | AORT |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 2.1B |
| IPO Year | 2021 | 1993 |
| Metric | TUYA | AORT |
|---|---|---|
| Price | $2.27 | $43.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.49 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 1.0M | 322.1K |
| Earning Date | 02-25-2026 | 02-23-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | $319,363,000.00 | ★ $422,646,000.00 |
| Revenue This Year | $8.84 | $15.97 |
| Revenue Next Year | $12.17 | $10.96 |
| P/E Ratio | $28.75 | ★ N/A |
| Revenue Growth | ★ 13.66 | 9.81 |
| 52 Week Low | $1.75 | $21.97 |
| 52 Week High | $4.63 | $48.25 |
| Indicator | TUYA | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 40.55 |
| Support Level | $2.19 | $41.82 |
| Resistance Level | $2.45 | $45.99 |
| Average True Range (ATR) | 0.08 | 1.38 |
| MACD | 0.00 | -0.28 |
| Stochastic Oscillator | 47.89 | 33.07 |
Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.